Literature DB >> 28275506

Current trends in lung resection for T1a non-small cell lung cancer: is lobectomy still the answer?

Syed S Razi1, Despoina Daskalaki1, Joshua Burack1.   

Abstract

Entities:  

Year:  2017        PMID： 28275506      PMCID： PMC5334112          DOI： 10.21037/jtd.2017.02.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.

Authors:  Max Kates; Scott Swanson; Juan P Wisnivesky
Journal:  Chest       Date:  2010-06-24       Impact factor: 9.410

4.  Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.

Authors:  Onkar V Khullar; Yuan Liu; Theresa Gillespie; Kristin A Higgins; Suresh Ramalingam; Joseph Lipscomb; Felix G Fernandez
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609

5.  The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; John Crowley; David Ball; Jhingook Kim; Gustavo Lyons; Thomas Rice; Kenji Suzuki; Charles F Thomas; William D Travis; Yi-Long Wu
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

6.  Non-small cell lung cancer, version 2.2013.

Authors:  David S Ettinger; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Ramaswamy Govindan; Frederic W Grannis; Stefan C Grant; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Feng-Ming Spring Kong; Mark G Kris; Lee M Krug; Rudy P Lackner; Inga T Lennes; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Douglas E Wood; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-06-01       Impact factor: 11.908

7.  Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.

Authors:  Chenyang Dai; Jianfei Shen; Yijiu Ren; Shengyi Zhong; Hui Zheng; Jiaxi He; Dong Xie; Ke Fei; Wenhua Liang; Gening Jiang; Ping Yang; Rene Horsleben Petersen; Calvin S H Ng; Chia-Chuan Liu; Gaetano Rocco; Alessandro Brunelli; Yaxing Shen; Chang Chen; Jianxing He
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

8.  Margin and local recurrence after sublobar resection of non-small cell lung cancer.

Authors:  Amgad El-Sherif; Hiran C Fernando; Ricardo Santos; Brian Pettiford; James D Luketich; John M Close; Rodney J Landreneau
Journal:  Ann Surg Oncol       Date:  2007-05-16       Impact factor: 5.344

9.  Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.

Authors:  Syed S Razi; Mohan M John; Sandeep Sainathan; Christos Stavropoulos
Journal:  J Surg Res       Date:  2015-09-03       Impact factor: 2.192
  9 in total
  2 in total

1.  What is the role of wedge resection for T1a lung cancer?

Authors:  Sebron Harrison; Brendon Stiles; Nasser Altorki
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Target volume definition for staple line recurrences of non-small cell lung cancer.

Authors:  Jan Nuzhat; Nitai D Mukhopadhyay; Elisabeth Weiss
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.